MCL1, a member of the BCL-2 family, inhibits apoptosis by sequestering pro-apoptotic factors at the mitochondrial outer membrane, and its overexpression has been frequently observed in various human malignancies, contributing to tumor progression and therapeutic resistance [33,34]. Here, MCL1 is linked to neoplasm.